Premier Brands

View our Distribution Partners

SDS

Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Email Subscription Centre

To receive the information that is relevant to your work, explore our subscription center and set your preferences

Contact Us

Customer Service:
Toll Free: 1800 800 097
Direct: 61 2 9841 0555

Special Offers

View our current Promotions, Offers and Discounts

Reliable Alternative to Santa Cruz Antibodies

Get easy access to our growing collection of world-class antibodies

NIST Standard Reference Materials SRMs

NIST Offers a Comprehensive Portfolio of SRMs applicable for calibration, validation, method development, quality control and trueness estimation in analytical laboratories.

Roche Biochemical Reagents

Roche's core Biochemical Reagents products are now available exclusively through Sigma-Aldrich

News & Information

Darmstadt, Germany - August 19, 2019 Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

Merck KGaA, Darmstadt, Germany today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene-editing technology, bringing the number of patents to 20 worldwide.

Read More
Darmstadt, Germany - August 6, 2019 Merck KGaA, Darmstadt, Germany Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab

Merck KGaA, Darmstadt, Germany has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving.

Read More
Shanghai, China - July 24, 2019 Merck KGaA, Darmstadt, Germany to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

Merck KGaA, Darmstadt, Germany today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.

Read More